At a glance
ClinicalIndex Comparison RecordN/ACompleted· 77 enrolled
Drug / intervention
Furosemidedrug
Likely dose
Furosemide 1 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Protocol to Assess the Severity of Acute Kidney Injury
In Brief
A clinical study evaluating Furosemide for Acute Kidney Failure. Completed, enrolled 77 participants across 1 site.
Detailed Summary
The principal objective is to safely determine if we can identify the severity of Acute Kidney Injury (AKI) early in the course of the disease. Once enrolled, we will draw blood and urine for relevant biomarkers. Our goal is to validate if any of these biomarkers can predict the course of AKI (recovery v. RRT v. death)
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Kidney Failure
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedMay 2008
Primary CompletionDec 2013
TodayJul 2026
First PostedMay 7, 2008
Enrollment StartApr 1, 2008
Primary CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 18.2 years ago
Interventions
Furosemidedrug
One dose: 1 mg/kg (iv)if the patient is furosemide naive or 1.5 mg/kg (iv) if patient is not furosemide naive.